Global Natural Killer Cells Therapeutics Market Research Report 2026(Status and Outlook)
Cell therapy, a new therapeutic approach that uses a patient"s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body"s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
The global Natural Killer Cells Therapeutics market size was estimated at USD 290.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Natural Killer Cells Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Natural Killer Cells Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Natural Killer Cells Therapeutics market.
Global Natural Killer Cells Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Affimed
Celgene Corporation
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Market Segmentation (by Type)
NK Cell Therapies
NK Cell Directed Antibodies
Market Segmentation (by Application)
Research Centers & Institutes
Hospitals
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Natural Killer Cells Therapeutics Market
Overview of the regional outlook of the Natural Killer Cells Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Natural Killer Cells Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Natural Killer Cells Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Natural Killer Cells Therapeutics market size was estimated at USD 290.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Natural Killer Cells Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Natural Killer Cells Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Natural Killer Cells Therapeutics market.
Global Natural Killer Cells Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Affimed
Celgene Corporation
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Market Segmentation (by Type)
NK Cell Therapies
NK Cell Directed Antibodies
Market Segmentation (by Application)
Research Centers & Institutes
Hospitals
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Natural Killer Cells Therapeutics Market
Overview of the regional outlook of the Natural Killer Cells Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Natural Killer Cells Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Natural Killer Cells Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Natural Killer Cells Therapeutics
1.2 Key Market Segments
1.2.1 Natural Killer Cells Therapeutics Segment by Type
1.2.2 Natural Killer Cells Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NATURAL KILLER CELLS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Natural Killer Cells Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Natural Killer Cells Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NATURAL KILLER CELLS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Natural Killer Cells Therapeutics Product Life Cycle
3.3 Global Natural Killer Cells Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Natural Killer Cells Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Natural Killer Cells Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Natural Killer Cells Therapeutics Market Competitive Situation and Trends
3.8.1 Natural Killer Cells Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Natural Killer Cells Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NATURAL KILLER CELLS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Natural Killer Cells Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NATURAL KILLER CELLS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Natural Killer Cells Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Natural Killer Cells Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 NATURAL KILLER CELLS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Natural Killer Cells Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Natural Killer Cells Therapeutics Market Size by Type (2020-2025)
6.4 Global Natural Killer Cells Therapeutics Price by Type (2020-2025)
7 NATURAL KILLER CELLS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Natural Killer Cells Therapeutics Market Sales by Application (2020-2025)
7.3 Global Natural Killer Cells Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2020-2025)
8 NATURAL KILLER CELLS THERAPEUTICS MARKET SALES BY REGION
8.1 Global Natural Killer Cells Therapeutics Sales by Region
8.1.1 Global Natural Killer Cells Therapeutics Sales by Region
8.1.2 Global Natural Killer Cells Therapeutics Sales Market Share by Region
8.2 Global Natural Killer Cells Therapeutics Market Size by Region
8.2.1 Global Natural Killer Cells Therapeutics Market Size by Region
8.2.2 Global Natural Killer Cells Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Natural Killer Cells Therapeutics Sales by Country
8.3.2 North America Natural Killer Cells Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Natural Killer Cells Therapeutics Sales by Country
8.4.2 Europe Natural Killer Cells Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Natural Killer Cells Therapeutics Sales by Region
8.5.2 Asia Pacific Natural Killer Cells Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Natural Killer Cells Therapeutics Sales by Country
8.6.2 South America Natural Killer Cells Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Natural Killer Cells Therapeutics Sales by Region
8.7.2 Middle East and Africa Natural Killer Cells Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NATURAL KILLER CELLS THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Natural Killer Cells Therapeutics by Region(2020-2025)
9.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Natural Killer Cells Therapeutics Production
9.4.1 North America Natural Killer Cells Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Natural Killer Cells Therapeutics Production
9.5.1 Europe Natural Killer Cells Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Natural Killer Cells Therapeutics Production (2020-2025)
9.6.1 Japan Natural Killer Cells Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Natural Killer Cells Therapeutics Production (2020-2025)
9.7.1 China Natural Killer Cells Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Affimed
10.1.1 Affimed Basic Information
10.1.2 Affimed Natural Killer Cells Therapeutics Product Overview
10.1.3 Affimed Natural Killer Cells Therapeutics Product Market Performance
10.1.4 Affimed Business Overview
10.1.5 Affimed SWOT Analysis
10.1.6 Affimed Recent Developments
10.2 Celgene Corporation
10.2.1 Celgene Corporation Basic Information
10.2.2 Celgene Corporation Natural Killer Cells Therapeutics Product Overview
10.2.3 Celgene Corporation Natural Killer Cells Therapeutics Product Market Performance
10.2.4 Celgene Corporation Business Overview
10.2.5 Celgene Corporation SWOT Analysis
10.2.6 Celgene Corporation Recent Developments
10.3 Fate Therapeutics
10.3.1 Fate Therapeutics Basic Information
10.3.2 Fate Therapeutics Natural Killer Cells Therapeutics Product Overview
10.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.3.4 Fate Therapeutics Business Overview
10.3.5 Fate Therapeutics SWOT Analysis
10.3.6 Fate Therapeutics Recent Developments
10.4 Fortress Biotech
10.4.1 Fortress Biotech Basic Information
10.4.2 Fortress Biotech Natural Killer Cells Therapeutics Product Overview
10.4.3 Fortress Biotech Natural Killer Cells Therapeutics Product Market Performance
10.4.4 Fortress Biotech Business Overview
10.4.5 Fortress Biotech Recent Developments
10.5 Glycostem Therapeutics
10.5.1 Glycostem Therapeutics Basic Information
10.5.2 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Overview
10.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.5.4 Glycostem Therapeutics Business Overview
10.5.5 Glycostem Therapeutics Recent Developments
10.6 Innate Pharma
10.6.1 Innate Pharma Basic Information
10.6.2 Innate Pharma Natural Killer Cells Therapeutics Product Overview
10.6.3 Innate Pharma Natural Killer Cells Therapeutics Product Market Performance
10.6.4 Innate Pharma Business Overview
10.6.5 Innate Pharma Recent Developments
10.7 Nantkwest
10.7.1 Nantkwest Basic Information
10.7.2 Nantkwest Natural Killer Cells Therapeutics Product Overview
10.7.3 Nantkwest Natural Killer Cells Therapeutics Product Market Performance
10.7.4 Nantkwest Business Overview
10.7.5 Nantkwest Recent Developments
10.8 Nkarta Therapeutics
10.8.1 Nkarta Therapeutics Basic Information
10.8.2 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Overview
10.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.8.4 Nkarta Therapeutics Business Overview
10.8.5 Nkarta Therapeutics Recent Developments
10.9 NKT Therapeutics
10.9.1 NKT Therapeutics Basic Information
10.9.2 NKT Therapeutics Natural Killer Cells Therapeutics Product Overview
10.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.9.4 NKT Therapeutics Business Overview
10.9.5 NKT Therapeutics Recent Developments
10.10 Ziopharm Oncology
10.10.1 Ziopharm Oncology Basic Information
10.10.2 Ziopharm Oncology Natural Killer Cells Therapeutics Product Overview
10.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Product Market Performance
10.10.4 Ziopharm Oncology Business Overview
10.10.5 Ziopharm Oncology Recent Developments
11 NATURAL KILLER CELLS THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Natural Killer Cells Therapeutics Market Size Forecast
11.2 Global Natural Killer Cells Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Natural Killer Cells Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Natural Killer Cells Therapeutics Market Size Forecast by Region
11.2.4 South America Natural Killer Cells Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Natural Killer Cells Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Natural Killer Cells Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Natural Killer Cells Therapeutics by Type (2026-2035)
12.1.2 Global Natural Killer Cells Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Natural Killer Cells Therapeutics by Type (2026-2035)
12.2 Global Natural Killer Cells Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Natural Killer Cells Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Natural Killer Cells Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Natural Killer Cells Therapeutics
1.2 Key Market Segments
1.2.1 Natural Killer Cells Therapeutics Segment by Type
1.2.2 Natural Killer Cells Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NATURAL KILLER CELLS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Natural Killer Cells Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Natural Killer Cells Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NATURAL KILLER CELLS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Natural Killer Cells Therapeutics Product Life Cycle
3.3 Global Natural Killer Cells Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Natural Killer Cells Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Natural Killer Cells Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Natural Killer Cells Therapeutics Market Competitive Situation and Trends
3.8.1 Natural Killer Cells Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Natural Killer Cells Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NATURAL KILLER CELLS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Natural Killer Cells Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NATURAL KILLER CELLS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Natural Killer Cells Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Natural Killer Cells Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 NATURAL KILLER CELLS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Natural Killer Cells Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Natural Killer Cells Therapeutics Market Size by Type (2020-2025)
6.4 Global Natural Killer Cells Therapeutics Price by Type (2020-2025)
7 NATURAL KILLER CELLS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Natural Killer Cells Therapeutics Market Sales by Application (2020-2025)
7.3 Global Natural Killer Cells Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2020-2025)
8 NATURAL KILLER CELLS THERAPEUTICS MARKET SALES BY REGION
8.1 Global Natural Killer Cells Therapeutics Sales by Region
8.1.1 Global Natural Killer Cells Therapeutics Sales by Region
8.1.2 Global Natural Killer Cells Therapeutics Sales Market Share by Region
8.2 Global Natural Killer Cells Therapeutics Market Size by Region
8.2.1 Global Natural Killer Cells Therapeutics Market Size by Region
8.2.2 Global Natural Killer Cells Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Natural Killer Cells Therapeutics Sales by Country
8.3.2 North America Natural Killer Cells Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Natural Killer Cells Therapeutics Sales by Country
8.4.2 Europe Natural Killer Cells Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Natural Killer Cells Therapeutics Sales by Region
8.5.2 Asia Pacific Natural Killer Cells Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Natural Killer Cells Therapeutics Sales by Country
8.6.2 South America Natural Killer Cells Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Natural Killer Cells Therapeutics Sales by Region
8.7.2 Middle East and Africa Natural Killer Cells Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NATURAL KILLER CELLS THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Natural Killer Cells Therapeutics by Region(2020-2025)
9.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Natural Killer Cells Therapeutics Production
9.4.1 North America Natural Killer Cells Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Natural Killer Cells Therapeutics Production
9.5.1 Europe Natural Killer Cells Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Natural Killer Cells Therapeutics Production (2020-2025)
9.6.1 Japan Natural Killer Cells Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Natural Killer Cells Therapeutics Production (2020-2025)
9.7.1 China Natural Killer Cells Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Affimed
10.1.1 Affimed Basic Information
10.1.2 Affimed Natural Killer Cells Therapeutics Product Overview
10.1.3 Affimed Natural Killer Cells Therapeutics Product Market Performance
10.1.4 Affimed Business Overview
10.1.5 Affimed SWOT Analysis
10.1.6 Affimed Recent Developments
10.2 Celgene Corporation
10.2.1 Celgene Corporation Basic Information
10.2.2 Celgene Corporation Natural Killer Cells Therapeutics Product Overview
10.2.3 Celgene Corporation Natural Killer Cells Therapeutics Product Market Performance
10.2.4 Celgene Corporation Business Overview
10.2.5 Celgene Corporation SWOT Analysis
10.2.6 Celgene Corporation Recent Developments
10.3 Fate Therapeutics
10.3.1 Fate Therapeutics Basic Information
10.3.2 Fate Therapeutics Natural Killer Cells Therapeutics Product Overview
10.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.3.4 Fate Therapeutics Business Overview
10.3.5 Fate Therapeutics SWOT Analysis
10.3.6 Fate Therapeutics Recent Developments
10.4 Fortress Biotech
10.4.1 Fortress Biotech Basic Information
10.4.2 Fortress Biotech Natural Killer Cells Therapeutics Product Overview
10.4.3 Fortress Biotech Natural Killer Cells Therapeutics Product Market Performance
10.4.4 Fortress Biotech Business Overview
10.4.5 Fortress Biotech Recent Developments
10.5 Glycostem Therapeutics
10.5.1 Glycostem Therapeutics Basic Information
10.5.2 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Overview
10.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.5.4 Glycostem Therapeutics Business Overview
10.5.5 Glycostem Therapeutics Recent Developments
10.6 Innate Pharma
10.6.1 Innate Pharma Basic Information
10.6.2 Innate Pharma Natural Killer Cells Therapeutics Product Overview
10.6.3 Innate Pharma Natural Killer Cells Therapeutics Product Market Performance
10.6.4 Innate Pharma Business Overview
10.6.5 Innate Pharma Recent Developments
10.7 Nantkwest
10.7.1 Nantkwest Basic Information
10.7.2 Nantkwest Natural Killer Cells Therapeutics Product Overview
10.7.3 Nantkwest Natural Killer Cells Therapeutics Product Market Performance
10.7.4 Nantkwest Business Overview
10.7.5 Nantkwest Recent Developments
10.8 Nkarta Therapeutics
10.8.1 Nkarta Therapeutics Basic Information
10.8.2 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Overview
10.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.8.4 Nkarta Therapeutics Business Overview
10.8.5 Nkarta Therapeutics Recent Developments
10.9 NKT Therapeutics
10.9.1 NKT Therapeutics Basic Information
10.9.2 NKT Therapeutics Natural Killer Cells Therapeutics Product Overview
10.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.9.4 NKT Therapeutics Business Overview
10.9.5 NKT Therapeutics Recent Developments
10.10 Ziopharm Oncology
10.10.1 Ziopharm Oncology Basic Information
10.10.2 Ziopharm Oncology Natural Killer Cells Therapeutics Product Overview
10.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Product Market Performance
10.10.4 Ziopharm Oncology Business Overview
10.10.5 Ziopharm Oncology Recent Developments
11 NATURAL KILLER CELLS THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Natural Killer Cells Therapeutics Market Size Forecast
11.2 Global Natural Killer Cells Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Natural Killer Cells Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Natural Killer Cells Therapeutics Market Size Forecast by Region
11.2.4 South America Natural Killer Cells Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Natural Killer Cells Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Natural Killer Cells Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Natural Killer Cells Therapeutics by Type (2026-2035)
12.1.2 Global Natural Killer Cells Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Natural Killer Cells Therapeutics by Type (2026-2035)
12.2 Global Natural Killer Cells Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Natural Killer Cells Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Natural Killer Cells Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Natural Killer Cells Therapeutics Market Size by Type (M USD)
Table 4. Global Natural Killer Cells Therapeutics Market Size by Application
Table 5. Natural Killer Cells Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Natural Killer Cells Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Natural Killer Cells Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Natural Killer Cells Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Natural Killer Cells Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2025)
Table 11. Global Market Natural Killer Cells Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Natural Killer Cells Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Natural Killer Cells Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Natural Killer Cells Therapeutics Sales by Type (K Units)
Table 27. Global Natural Killer Cells Therapeutics Market Size by Type (M USD)
Table 28. Global Natural Killer Cells Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Natural Killer Cells Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Natural Killer Cells Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Natural Killer Cells Therapeutics Market Share by Type (2020-2025)
Table 32. Global Natural Killer Cells Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Natural Killer Cells Therapeutics Sales (K Units) by Application
Table 34. Global Natural Killer Cells Therapeutics Market Size by Application
Table 35. Global Natural Killer Cells Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Natural Killer Cells Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Natural Killer Cells Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Natural Killer Cells Therapeutics Market Share by Application (2020-2025)
Table 39. Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Natural Killer Cells Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Natural Killer Cells Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Natural Killer Cells Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Natural Killer Cells Therapeutics Market Size by Region (2020-2025)
Table 44. North America Natural Killer Cells Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Natural Killer Cells Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Natural Killer Cells Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Natural Killer Cells Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Natural Killer Cells Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Natural Killer Cells Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Natural Killer Cells Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Natural Killer Cells Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Natural Killer Cells Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Natural Killer Cells Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Natural Killer Cells Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Natural Killer Cells Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Natural Killer Cells Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Natural Killer Cells Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Natural Killer Cells Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Natural Killer Cells Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Natural Killer Cells Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Natural Killer Cells Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Affimed Basic Information
Table 63. Affimed Natural Killer Cells Therapeutics Product Overview
Table 64. Affimed Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Affimed Business Overview
Table 66. Affimed SWOT Analysis
Table 67. Affimed Recent Developments
Table 68. Celgene Corporation Basic Information
Table 69. Celgene Corporation Natural Killer Cells Therapeutics Product Overview
Table 70. Celgene Corporation Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Celgene Corporation Business Overview
Table 72. Celgene Corporation SWOT Analysis
Table 73. Celgene Corporation Recent Developments
Table 74. Fate Therapeutics Basic Information
Table 75. Fate Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 76. Fate Therapeutics Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Fate Therapeutics Business Overview
Table 78. Fate Therapeutics SWOT Analysis
Table 79. Fate Therapeutics Recent Developments
Table 80. Fortress Biotech Basic Information
Table 81. Fortress Biotech Natural Killer Cells Therapeutics Product Overview
Table 82. Fortress Biotech Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Fortress Biotech Business Overview
Table 84. Fortress Biotech Recent Developments
Table 85. Glycostem Therapeutics Basic Information
Table 86. Glycostem Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 87. Glycostem Therapeutics Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Glycostem Therapeutics Business Overview
Table 89. Glycostem Therapeutics Recent Developments
Table 90. Innate Pharma Basic Information
Table 91. Innate Pharma Natural Killer Cells Therapeutics Product Overview
Table 92. Innate Pharma Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Innate Pharma Business Overview
Table 94. Innate Pharma Recent Developments
Table 95. Nantkwest Basic Information
Table 96. Nantkwest Natural Killer Cells Therapeutics Product Overview
Table 97. Nantkwest Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Nantkwest Business Overview
Table 99. Nantkwest Recent Developments
Table 100. Nkarta Therapeutics Basic Information
Table 101. Nkarta Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 102. Nkarta Therapeutics Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Nkarta Therapeutics Business Overview
Table 104. Nkarta Therapeutics Recent Developments
Table 105. NKT Therapeutics Basic Information
Table 106. NKT Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 107. NKT Therapeutics Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. NKT Therapeutics Business Overview
Table 109. NKT Therapeutics Recent Developments
Table 110. Ziopharm Oncology Basic Information
Table 111. Ziopharm Oncology Natural Killer Cells Therapeutics Product Overview
Table 112. Ziopharm Oncology Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Ziopharm Oncology Business Overview
Table 114. Ziopharm Oncology Recent Developments
Table 115. Global Natural Killer Cells Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Natural Killer Cells Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Natural Killer Cells Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Natural Killer Cells Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Natural Killer Cells Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Natural Killer Cells Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Natural Killer Cells Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Natural Killer Cells Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Natural Killer Cells Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Natural Killer Cells Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Natural Killer Cells Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Natural Killer Cells Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Natural Killer Cells Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Natural Killer Cells Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Natural Killer Cells Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Natural Killer Cells Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Natural Killer Cells Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Natural Killer Cells Therapeutics Market Size by Type (M USD)
Table 4. Global Natural Killer Cells Therapeutics Market Size by Application
Table 5. Natural Killer Cells Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Natural Killer Cells Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Natural Killer Cells Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Natural Killer Cells Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Natural Killer Cells Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2025)
Table 11. Global Market Natural Killer Cells Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Natural Killer Cells Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Natural Killer Cells Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Natural Killer Cells Therapeutics Sales by Type (K Units)
Table 27. Global Natural Killer Cells Therapeutics Market Size by Type (M USD)
Table 28. Global Natural Killer Cells Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Natural Killer Cells Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Natural Killer Cells Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Natural Killer Cells Therapeutics Market Share by Type (2020-2025)
Table 32. Global Natural Killer Cells Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Natural Killer Cells Therapeutics Sales (K Units) by Application
Table 34. Global Natural Killer Cells Therapeutics Market Size by Application
Table 35. Global Natural Killer Cells Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Natural Killer Cells Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Natural Killer Cells Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Natural Killer Cells Therapeutics Market Share by Application (2020-2025)
Table 39. Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Natural Killer Cells Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Natural Killer Cells Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Natural Killer Cells Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Natural Killer Cells Therapeutics Market Size by Region (2020-2025)
Table 44. North America Natural Killer Cells Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Natural Killer Cells Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Natural Killer Cells Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Natural Killer Cells Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Natural Killer Cells Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Natural Killer Cells Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Natural Killer Cells Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Natural Killer Cells Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Natural Killer Cells Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Natural Killer Cells Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Natural Killer Cells Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Natural Killer Cells Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Natural Killer Cells Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Natural Killer Cells Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Natural Killer Cells Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Natural Killer Cells Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Natural Killer Cells Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Natural Killer Cells Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Affimed Basic Information
Table 63. Affimed Natural Killer Cells Therapeutics Product Overview
Table 64. Affimed Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Affimed Business Overview
Table 66. Affimed SWOT Analysis
Table 67. Affimed Recent Developments
Table 68. Celgene Corporation Basic Information
Table 69. Celgene Corporation Natural Killer Cells Therapeutics Product Overview
Table 70. Celgene Corporation Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Celgene Corporation Business Overview
Table 72. Celgene Corporation SWOT Analysis
Table 73. Celgene Corporation Recent Developments
Table 74. Fate Therapeutics Basic Information
Table 75. Fate Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 76. Fate Therapeutics Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Fate Therapeutics Business Overview
Table 78. Fate Therapeutics SWOT Analysis
Table 79. Fate Therapeutics Recent Developments
Table 80. Fortress Biotech Basic Information
Table 81. Fortress Biotech Natural Killer Cells Therapeutics Product Overview
Table 82. Fortress Biotech Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Fortress Biotech Business Overview
Table 84. Fortress Biotech Recent Developments
Table 85. Glycostem Therapeutics Basic Information
Table 86. Glycostem Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 87. Glycostem Therapeutics Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Glycostem Therapeutics Business Overview
Table 89. Glycostem Therapeutics Recent Developments
Table 90. Innate Pharma Basic Information
Table 91. Innate Pharma Natural Killer Cells Therapeutics Product Overview
Table 92. Innate Pharma Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Innate Pharma Business Overview
Table 94. Innate Pharma Recent Developments
Table 95. Nantkwest Basic Information
Table 96. Nantkwest Natural Killer Cells Therapeutics Product Overview
Table 97. Nantkwest Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Nantkwest Business Overview
Table 99. Nantkwest Recent Developments
Table 100. Nkarta Therapeutics Basic Information
Table 101. Nkarta Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 102. Nkarta Therapeutics Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Nkarta Therapeutics Business Overview
Table 104. Nkarta Therapeutics Recent Developments
Table 105. NKT Therapeutics Basic Information
Table 106. NKT Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 107. NKT Therapeutics Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. NKT Therapeutics Business Overview
Table 109. NKT Therapeutics Recent Developments
Table 110. Ziopharm Oncology Basic Information
Table 111. Ziopharm Oncology Natural Killer Cells Therapeutics Product Overview
Table 112. Ziopharm Oncology Natural Killer Cells Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Ziopharm Oncology Business Overview
Table 114. Ziopharm Oncology Recent Developments
Table 115. Global Natural Killer Cells Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Natural Killer Cells Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Natural Killer Cells Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Natural Killer Cells Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Natural Killer Cells Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Natural Killer Cells Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Natural Killer Cells Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Natural Killer Cells Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Natural Killer Cells Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Natural Killer Cells Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Natural Killer Cells Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Natural Killer Cells Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Natural Killer Cells Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Natural Killer Cells Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Natural Killer Cells Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Natural Killer Cells Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Natural Killer Cells Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Natural Killer Cells Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Natural Killer Cells Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Natural Killer Cells Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Natural Killer Cells Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Natural Killer Cells Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Natural Killer Cells Therapeutics Product Life Cycle
Figure 13. Natural Killer Cells Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Natural Killer Cells Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Natural Killer Cells Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Natural Killer Cells Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Natural Killer Cells Therapeutics
Figure 19. Global Natural Killer Cells Therapeutics Market PEST Analysis
Figure 20. Global Natural Killer Cells Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Natural Killer Cells Therapeutics Market Share by Type
Figure 27. Sales Market Share of Natural Killer Cells Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Natural Killer Cells Therapeutics by Type in 2025
Figure 29. Market Share of Natural Killer Cells Therapeutics by Type (2020-2025)
Figure 30. Market Share of Natural Killer Cells Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Natural Killer Cells Therapeutics Market Share by Application
Figure 33. Global Natural Killer Cells Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Natural Killer Cells Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Natural Killer Cells Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Natural Killer Cells Therapeutics Market Share by Application in 2025
Figure 37. Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Natural Killer Cells Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Natural Killer Cells Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Natural Killer Cells Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Natural Killer Cells Therapeutics Market Size by Country in 2024
Figure 45. U.S. Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Natural Killer Cells Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Natural Killer Cells Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Natural Killer Cells Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Natural Killer Cells Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Natural Killer Cells Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Natural Killer Cells Therapeutics Market Size by Country in 2024
Figure 55. Germany Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Natural Killer Cells Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Natural Killer Cells Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Natural Killer Cells Therapeutics Market Size by Region in 2024
Figure 68. China Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Natural Killer Cells Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Natural Killer Cells Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Natural Killer Cells Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Natural Killer Cells Therapeutics Market Size by Country in 2024
Figure 82. Brazil Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Natural Killer Cells Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Natural Killer Cells Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Natural Killer Cells Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Natural Killer Cells Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Natural Killer Cells Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Natural Killer Cells Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Natural Killer Cells Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Natural Killer Cells Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Natural Killer Cells Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Natural Killer Cells Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Natural Killer Cells Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Natural Killer Cells Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Natural Killer Cells Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Natural Killer Cells Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Natural Killer Cells Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Natural Killer Cells Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Natural Killer Cells Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Natural Killer Cells Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Natural Killer Cells Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Natural Killer Cells Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Natural Killer Cells Therapeutics Product Life Cycle
Figure 13. Natural Killer Cells Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Natural Killer Cells Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Natural Killer Cells Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Natural Killer Cells Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Natural Killer Cells Therapeutics
Figure 19. Global Natural Killer Cells Therapeutics Market PEST Analysis
Figure 20. Global Natural Killer Cells Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Natural Killer Cells Therapeutics Market Share by Type
Figure 27. Sales Market Share of Natural Killer Cells Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Natural Killer Cells Therapeutics by Type in 2025
Figure 29. Market Share of Natural Killer Cells Therapeutics by Type (2020-2025)
Figure 30. Market Share of Natural Killer Cells Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Natural Killer Cells Therapeutics Market Share by Application
Figure 33. Global Natural Killer Cells Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Natural Killer Cells Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Natural Killer Cells Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Natural Killer Cells Therapeutics Market Share by Application in 2025
Figure 37. Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Natural Killer Cells Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Natural Killer Cells Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Natural Killer Cells Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Natural Killer Cells Therapeutics Market Size by Country in 2024
Figure 45. U.S. Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Natural Killer Cells Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Natural Killer Cells Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Natural Killer Cells Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Natural Killer Cells Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Natural Killer Cells Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Natural Killer Cells Therapeutics Market Size by Country in 2024
Figure 55. Germany Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Natural Killer Cells Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Natural Killer Cells Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Natural Killer Cells Therapeutics Market Size by Region in 2024
Figure 68. China Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Natural Killer Cells Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Natural Killer Cells Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Natural Killer Cells Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Natural Killer Cells Therapeutics Market Size by Country in 2024
Figure 82. Brazil Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Natural Killer Cells Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Natural Killer Cells Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Natural Killer Cells Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Natural Killer Cells Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Natural Killer Cells Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Natural Killer Cells Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Natural Killer Cells Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Natural Killer Cells Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Natural Killer Cells Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Natural Killer Cells Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Natural Killer Cells Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Natural Killer Cells Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Natural Killer Cells Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Natural Killer Cells Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Natural Killer Cells Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Natural Killer Cells Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Natural Killer Cells Therapeutics Market Share Forecast by Application (2026-2035)
